Breaking News - The Fly

Open Search

OXBDF

Oxford Biomedica

$

()

Oxford Biomedica sees FY23 revenue GBP 90M

OXBDF

3/5/2024 - 07:17am

Oxford Biomedica completes acquisition of ABL Europe

OXBDF

1/29/2024 - 07:07am

Oxford Biomedica on track to deliver 2023 revenues of GBP 90M

OXBDF

12/7/2023 - 07:03am

Oxford says continuing to demonstrate 'robust' business development activity

OXBDF

12/7/2023 - 07:03am

Oxford Biomedica to acquire ABL Europe from Institut Merieux

OXBDF

12/4/2023 - 07:10am

Oxford Biomedica price target lowered to 325 GBp from 495 GBp at JPMorgan

OXBDF

9/22/2023 - 15:50pm

Oxford Biomedica, Institut Merieux enter exclusive negotations for ABL Europe

OXBDF

9/20/2023 - 07:55am

Oxford Biomedica sees 2023 group revenues GBP 90M

OXBDF

9/20/2023 - 07:49am

Oxford Biomedica reports 1H EPS (49.74p) vs. (27.29p) last year

OXBDF

9/20/2023 - 07:48am

Oxford Biomedica downgraded to Hold from Buy at Liberum

OXBDF

9/4/2023 - 09:14am

Oxford Biomedica downgraded to Hold from Buy at Stifel

OXBDF

8/4/2023 - 05:21am

Oxford Biomedica initiated with a Neutral at JPMorgan

OXBDF

6/20/2023 - 20:19pm

Oxford Biomedica price target lowered to 1,010 GBp at RBC Capital

OXBDF

5/24/2023 - 14:50pm

Oxford Biomedica launches TetraVecta lentiviral vector system

OXBDF

5/15/2023 - 07:24am

Oxford Biomedica initiated with an Overweight at Cantor Fitzgerald

OXBDF

5/3/2023 - 06:55am